JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511237200 on February 17, 2006

J. Biol. Chem., Vol. 281, Issue 16, 10849-10855, April 21, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/16/10849    most recent
M511237200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, L.
Right arrow Articles by Wang, X. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, L.
Right arrow Articles by Wang, X. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Human Prolyl-4-hydroxylase {alpha}(I) Transcription Is Mediated by Upstream Stimulatory Factors*

Li Chen{ddagger}§, Ying H. Shen{ddagger}§, Xinwen Wang{ddagger}§, Jing Wang{ddagger}§, Yehua Gan{ddagger}§, Nanyue Chen, Jian Wang{ddagger}§, Scott A. LeMaire{ddagger}§, Joseph S. Coselli{ddagger}§, and Xing Li Wang{ddagger}§1

From the {ddagger}Section of Adult Cardiothoracic Service, Texas Heart Institute at St. Luke's Episcopal Hospital and §Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030 and Department of Molecular Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030

Prolyl-4-hydroxylase {alpha}(I) (P4H{alpha}(I)) is the rate-limiting subunit for P4H enzyme activity, which is essential for procollagen hydroxylation and secretion. In the current study, we have characterized the human P4H{alpha}(I) promoter for transcription factors and DNA elements regulating P4H{alpha}(I) expression. Using a progressive deletion cloning approach, we have constructed pGL3-P4H{alpha}(I) recombinant plasmids. We have identified a positive regulatory region at the positions of bp –184 to –97 responsible for ~80% of the P4H{alpha}(I) promoter efficiency. Three E-boxes were located within this region, and the E-box at position bp –135 explains most of the regulatory capacity. Upstream stimulatory factors (USF1/USF2) were shown to bind on the E-box using chromatin immunoprecipitation assay. Suppression of USF1 and/or USF2 using specific short interference RNA resulted in a significant reduction in P4H{alpha}(I) promoter activity, and overexpressed USF1 or USF2 increased P4H{alpha}(I) promoter activity significantly. Although transforming growth factor beta1 increased the USF1/USF2-E-box binding and P4H{alpha}(I) promoter activity, this up-regulatory effect can be largely prevented by USF1/USF2-specific short interference RNA. On the other hand, cigarette smoking extracts, which have been shown to suppress P4H{alpha}(I) expression, inhibited the binding between the USF1/USF2 and E-box, resulting in a reduced P4H{alpha}(I) promoter activity. Furthermore, the E-box on the P4H{alpha}(I) promoter appeared to indiscriminately bind with either USF1 or USF2, with a similar outcome on the promoter efficiency. In conclusion, our study shows that USF1/USF2 plays a critical role in basal P4H{alpha}(I) expression, and both positive (transforming growth factor beta1) and negative (cigarette smoking extract) regulators appear to influence the USF-E-box interaction and affect P4H{alpha}(I) expression.


Received for publication, October 16, 2005 , and in revised form, January 23, 2006.

* This work was supported by American Heart Association Established Investigator Award AHA 0440001N (to X. L. W.) and National Institutes of Health Grants HL066053 and HL71608. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: NAB 2010, One Baylor Plaza, Baylor College of Medicine, Houston, TX 77030. Tel.: 713-798-5485; Fax: 713-798-1705; E-mail: xlwang{at}bcm.tmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Liu, L. Shi, and S. Wang
Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1727 - F1735.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Zhang, M.-X. Zhang, Y. H. Shen, J. K. Burks, Y. Zhang, J. Wang, S. A. LeMaire, K. Yoshimura, H. Aoki, J. S. Coselli, et al.
TNF-{alpha} Suppresses Prolyl-4-Hydroxylase {alpha}1 Expression via the ASK1-JNK-NonO Pathway
Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1760 - 1767.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-i. Asaka, T. Terada, K. Ogasawara, T. Katsura, and K.-i. Inui
Characterization of the Basal Promoter Element of Human Organic Cation Transporter 2 Gene
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 684 - 689.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.